I threw out a request on Twitter yesterday for 2013 biotech stock predictions. The response was amazing and overwhelming. Thanks to everyone who contributed. I'll be sure to check back throughout the year to check the accuracy of TheStreet's biotech readers.

If you agree, disagree or feel like something is missing from this list, please share your thoughts and comments below.

TheStreet readers' 2013 biotech stock predictions:

AMRN - still independent, launch sales - they will spend much more on mkting, admin, sales than actual gains from product sales. No NCE/— Sport234a2b (@Sport234a) January 1, 2013